Detecting what you introduced rather than what the cell makes: why gfp antibodies and an egfp antibody are the easiest validation available and still need a negative cell line, what an anti yfp antibody, a yfp antibody, an anti tdtomato antibody, an rfp antibody and a zsgreen antibody cross react with across the fluorescent protein family, how a luciferase antibody, an anti luciferase antibody, an anti-luciferase antibody and a firefly luciferase antibody differ by the enzyme they were raised against, where a beta galactosidase antibody, a cre antibody, a gal4 antibody, a cas9 antibody, an anti cas9 antibody, a crispr antibody and an apex2 antibody detect introduced machinery rather than a reporter, what a strep tag ii antibody, a gst antibody with its anti gst antibody, anti-gst antibody and gst tag antibody spellings, an mbp antibody, an anti mbp antibody and an anti-mbp antibody detect on a fusion, and why a digoxigenin antibody, an anti dig antibody, an anti biotin antibody, an anti streptavidin antibody, an anti-fitc antibody, a fitc antibody, a puromycin antibody, an anti puromycin antibody and an anti-puromycin antibody are detection chemistry rather than biology
Antibodies against introduced proteins are the cleanest reagents in a laboratory, because a cell line without the construct is a perfect negative control. That advantage is routinely wasted: the negative line is not run, cross reactivity within a fluorescent protein family is assumed away, and a tag is detected without checking the fusion is intact.
- good laboratory practice for nonclinical studies, 21 CFR
- Part 58
- the labelling clause behind research use only on an antibody
- 809.10(c)
- the biosafety manual that decides handling for primary material
- BMBL
The figures in this panel are regulation and manual identifiers, named from the documents themselves and linked below. They are not prices: BioBricks publishes verified prices for synthesis services only, and does not imply a reagent price index it has not measured.
- 4 vendor service pages verifiedevery figure matched verbatim to the vendor's page
- Quoted and dated, never estimatedlast verification pass 2026-08-24
- 1 service classes coveredeach with measured search demand behind it
Using tag reagents properly
- Run the untransduced line every time. A cell line lacking the construct is the ideal negative control and it costs one lane. Any signal there is background, and knowing its size makes every subsequent interpretation quantitative.
- Check cross reactivity across the family. Fluorescent proteins share substantial sequence, and a reagent raised against one frequently detects several. If two colours are used in the same experiment, confirm the reagents distinguish them before relying on either.
- Confirm the fusion is intact. A tag antibody reports the tag, and a cleaved or degraded fusion still carries it. Run the tag reagent and a reagent against the partner and check the bands agree in size before treating a tag signal as the protein.
- Choose the tag for the application. Small peptide tags are less likely to perturb function and are harder to detect at low abundance. Larger fusion tags detect easily and are more likely to interfere. Decide against the experiment rather than by habit.
- Keep detection chemistry separate in your thinking. Reagents against labels such as biotin, digoxigenin or a fluorophore are part of a detection layer. Treating them as target reagents leads to protocols where nobody can say what the signal reports.
The best control in the building
Almost no antibody experiment has a true negative sample available. Tag and reporter work does, because the parental line genuinely lacks the antigen. Laboratories that habitually run it get a clean measurement of background that transfers to every other stain on the same instrument.
Make it part of the protocol rather than an occasional check. It costs a lane and it settles arguments before they start.
Tags change the protein
A fusion tag can alter folding, localisation, turnover and interactions, and the effect depends on position. A construct that works for detection may not behave like the endogenous protein.
Where the conclusion depends on the protein behaving normally, compare tagged and untagged versions once, or use an endogenous tagging approach. It is the difference between a reporter and a proxy.
Common questions
- Do I still need controls for a tag antibody?
- Yes, and they are unusually easy: an untransduced line, and where possible a construct with the tag in another position. The convenience of the reagent is not a reason to skip the evidence.
- Will an antibody against one fluorescent protein detect another?
- Frequently, because the family shares sequence. Test it explicitly if two are used together, because a cross reacting reagent will quietly merge the two populations.
- Why does my tag blot show the wrong size?
- Degradation of the fusion, an unintended start site, or cleavage at a linker. Blot the partner as well and compare, because a tag signal at an unexpected size is information rather than noise.
Get a shortlist for your project
Browse by service class
Sources
Cite or embed this figure
The median advertised gene synthesis price per base pair in the US research synthesis services market was $0.11 in August 2026, across 4 verified vendor service pages recorded in BioBricks Synthesis Price Index.
Cite as: "BioBricks Synthesis Price Index", updated 2026-08-24, https://biobricks.org/gfp-antibodies/.